Search results
Here's How Moderna Plans to Win in the Post-Emergency COVID Vaccine Market
Motley Fool· 1 year agoHigh demand for coronavirus vaccines earlier in the pandemic pushed Moderna's (NASDAQ: MRNA)...
Moderna seeks US FDA authorization for updated COVID vaccine
Reuters via Yahoo News· 1 year agoThe submission from the company follows the FDA's advice last week to manufacturers that are...
Moderna Just Took a Step Closer to Its Product Launch Goal. Is the Stock a Buy?
Motley Fool via Yahoo Finance· 6 months agoModerna (NASDAQ: MRNA) today is known for its one and only product: the coronavirus vaccine now...
Moderna gives update on Covid vaccine coming this fall as cases rise across the US – latest news
The Independent UK via AOL· 10 months agoModerna released a statement Wednesday saying the company’s updated boosters are expected to work...
New Covid variant ‘Pirola’ sparks case rise across US and Canada as Moderna shares vaccine update –...
The Independent US via AOL· 10 months agoModerna released a statement Wednesday saying the company’s updated boosters are expected to work...
Moderna Investors Just Got Some Bullish News
The Motley Fool via AOL· 3 weeks agoModerna (NASDAQ: MRNA) jumped into the limelight when it started developing a coronavirus vaccine candidate. And the stock soared as the vaccine raced...
Is Moderna Heading for a Critical Moment?
Motley Fool· 12 months agoModerna (NASDAQ: MRNA) has generated billions of dollars in sales and profit from its coronavirus vaccine. This doesn't mean the revenue opportunity is...
Moderna sues Pfizer over patents behind COVID-19 vaccine
Associated Press via AOL· 2 years agoCOVID-19 vaccine maker Moderna is suing Pfizer and the German drugmaker BioNTech, accusing its main...
Pfizer and Moderna Don't See Eye to Eye on This 1 Particular Point
Motley Fool· 8 months agoPfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) have been in agreement on a lot since the beginning of...
Could Novavax Become the Next Moderna?
Motley Fool via Yahoo Finance· 1 month agoNovavax (NASDAQ: NVAX) and Moderna (NASDAQ: MRNA) both entered the coronavirus vaccine race around the same time, in early pandemic days, and their...
